Skip to main content

MARSHALL WACE, LLP

Position in NTRA — Natera, Inc.

CIK 1318757 LONDON, X0

Position in NTRA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,739,862
+$10,739,862 QoQ
Shares Held
53,702
Ownership
0.037%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NTRA Over Time

Shares Held

Position Value (USD)

Derivatives in NTRA

reported options exposure · as of Mar 31, 2026
CallValue
$179,991
CallShares
900
PutValue
$159,992
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $531,017,373 across 25 Diagnostics & Research names. NTRA ranks #8 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NTRA
Natera, Inc.
This page
53,702 $10,739,862

All Filings in NTRA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $159,992 800
2026-03-31 $179,991 900
2026-03-31 $10,739,862 53,702
2025-12-31 $183,272 800
2025-12-31 $114,545 500
2025-09-30 $772,656 4,800
2025-09-30 $1,706,282 10,600
2025-03-31 $37,408,883 264,542
2024-12-31 $13,487,160 85,200
2024-12-31 $68,771,218 434,436
2024-09-30 $57,260,288 451,046
2024-06-30 $103,783,293 958,383
2024-03-31 $57,048,449 623,753
2023-12-31 $27,367,478 436,901
2023-09-30 $36,026,136 814,150
2023-06-30 $68,664,466 1,411,107
2023-03-31 $73,716,957 1,327,755
2022-12-31 $59,938,660 1,492,125
2022-09-30 $53,862,886 1,229,185
2022-06-30 $44,577,352 1,257,826
2022-03-31 $57,420,063 1,411,506
2021-12-31 $169,588,674 1,815,919
2021-09-30 $151,531,765 1,359,761
2021-03-31 $119,209,280 1,174,013
2020-12-31 $90,687,998 911,254
2020-03-31 $1,322,290 44,283